ELEV Annual CFF
$47.98 M
+$18.46 M+62.55%
31 December 2023
Summary:
As of January 23, 2025, ELEV annual cash flow from financing activities is $47.98 million, with the most recent change of +$18.46 million (+62.55%) on December 31, 2023. During the last 3 years, it has fallen by -$42.05 million (-46.71%). ELEV annual CFF is now -50.57% below its all-time high of $97.05 million, reached on December 31, 2021.ELEV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV Quarterly CFF
$10.00 K
-$14.67 M-99.93%
30 September 2024
Summary:
As of January 23, 2025, ELEV quarterly cash flow from financing activities is $10.00 thousand, with the most recent change of -$14.67 million (-99.93%) on September 30, 2024. Over the past year, it has dropped by -$30.24 million (-99.97%). ELEV quarterly CFF is now -99.99% below its all-time high of $91.98 million, reached on June 30, 2021.ELEV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV TTM CFF
$44.94 M
-$17.00 K-0.04%
30 September 2024
Summary:
As of January 23, 2025, ELEV TTM cash flow from financing activities is $44.94 million, with the most recent change of -$17.00 thousand (-0.04%) on September 30, 2024. Over the past year, it has dropped by -$33.07 million (-42.39%). ELEV TTM CFF is now -72.24% below its all-time high of $161.88 million, reached on September 30, 2021.ELEV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.5% | -100.0% | -42.4% |
| 3 y3 years | -46.7% | +350.0% | +52.3% |
| 5 y5 years | - | +350.0% | +52.3% |
ELEV Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.6% | +62.5% | -100.0% | +140.0% | -53.7% | +784.8% |
| 5 y | 5-year | -50.6% | +62.5% | -100.0% | +140.0% | -72.2% | +784.8% |
| alltime | all time | -50.6% | +62.5% | -100.0% | +140.0% | -72.2% | +784.8% |
Elevation Oncology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.00 K(-99.9%) | $44.94 M(-0.0%) |
| June 2024 | - | $14.68 M(-51.5%) | $44.96 M(-42.4%) |
| Mar 2024 | - | $30.25 M(<-9900.0%) | $78.01 M(+62.6%) |
| Dec 2023 | $47.98 M(+62.5%) | -$2000.00(-107.4%) | $47.98 M(+0.0%) |
| Sept 2023 | - | $27.00 K(-99.9%) | $47.97 M(-38.1%) |
| June 2023 | - | $47.73 M(>+9900.0%) | $77.47 M(+160.7%) |
| Mar 2023 | - | $216.00 K(-5500.0%) | $29.71 M(+0.7%) |
| Dec 2022 | $29.51 M | -$4000.00(-100.0%) | $29.51 M(-0.0%) |
| Sept 2022 | - | $29.52 M(<-9900.0%) | $29.52 M(+481.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$25.00 K(-231.6%) | $5.08 M(-94.8%) |
| Mar 2022 | - | $19.00 K(>+9900.0%) | $97.08 M(+0.0%) |
| Dec 2021 | $97.05 M(+7.8%) | $0.00(-100.0%) | $97.05 M(-40.0%) |
| Sept 2021 | - | $5.08 M(-94.5%) | $161.88 M(+3.2%) |
| June 2021 | - | $91.98 M(<-9900.0%) | $156.81 M(+141.9%) |
| Mar 2021 | - | -$11.00 K(-100.0%) | $64.83 M(-28.0%) |
| Dec 2020 | $90.03 M | $64.83 M(>+9900.0%) | $90.03 M(+257.2%) |
| Sept 2020 | - | $20.00 K(>+9900.0%) | $25.20 M(+0.1%) |
| June 2020 | - | $0.00(-100.0%) | $25.18 M(0.0%) |
| Mar 2020 | - | $25.18 M | $25.18 M |
FAQ
- What is Elevation Oncology annual cash flow from financing activities?
- What is the all time high annual CFF for Elevation Oncology?
- What is Elevation Oncology annual CFF year-on-year change?
- What is Elevation Oncology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Elevation Oncology?
- What is Elevation Oncology quarterly CFF year-on-year change?
- What is Elevation Oncology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Elevation Oncology?
- What is Elevation Oncology TTM CFF year-on-year change?
What is Elevation Oncology annual cash flow from financing activities?
The current annual CFF of ELEV is $47.98 M
What is the all time high annual CFF for Elevation Oncology?
Elevation Oncology all-time high annual cash flow from financing activities is $97.05 M
What is Elevation Oncology annual CFF year-on-year change?
Over the past year, ELEV annual cash flow from financing activities has changed by +$18.46 M (+62.55%)
What is Elevation Oncology quarterly cash flow from financing activities?
The current quarterly CFF of ELEV is $10.00 K
What is the all time high quarterly CFF for Elevation Oncology?
Elevation Oncology all-time high quarterly cash flow from financing activities is $91.98 M
What is Elevation Oncology quarterly CFF year-on-year change?
Over the past year, ELEV quarterly cash flow from financing activities has changed by -$30.24 M (-99.97%)
What is Elevation Oncology TTM cash flow from financing activities?
The current TTM CFF of ELEV is $44.94 M
What is the all time high TTM CFF for Elevation Oncology?
Elevation Oncology all-time high TTM cash flow from financing activities is $161.88 M
What is Elevation Oncology TTM CFF year-on-year change?
Over the past year, ELEV TTM cash flow from financing activities has changed by -$33.07 M (-42.39%)